公开(公告)号：US20180044255A1

公开(公告)日：2018-02-15

申请号：US15792288

申请日：2017-10-24

申请人： Gary David McKnight ,  David Bruce Parker ,  Yang Zehni ,  Ray Perkins ,  Wei Xu

发明人： Gary David McKnight ,  David Bruce Parker ,  Yang Zehni ,  Ray Perkins ,  Wei Xu

IPC分类号： C05G3/08 ,  C05G3/00 ,  C05C9/00 ,  C09K15/28 ,  C07F9/22

CPC分类号： C05G3/08 ,  C05C9/00 ,  C05C9/005 ,  C05C9/02 ,  C05G3/0041 ,  C05G3/0064 ,  C07F9/224 ,  C09K15/28

摘要： An improved solvent system for the formulation and application of N-alkyl thiophosphoric triamide urease inhibitors. These formulations provide safety and performance benefits relative to existing alternatives and enable storage, transport and subsequent coating or blending with urea based or organic based fertilizers. These formulations are comprised primarily of environmentally friendly aprotic and protic solvents (particularly dimethyl sulfoxide and alcohols/polyols) to stabilize the urease inhibitor.

公开(公告)号：US09779106B2

公开(公告)日：2017-10-03

申请号：US14239186

申请日：2012-08-14

申请人： Wei Xu ,  Qiming Deng ,  Dong Chen ,  Sheng Wang ,  Shiguang Huang ,  Qing Liu ,  Yanxia Chen

发明人： Wei Xu ,  Qiming Deng ,  Dong Chen ,  Sheng Wang ,  Shiguang Huang ,  Qing Liu ,  Yanxia Chen

IPC分类号： G06F17/30 ,  G06F9/44 ,  G06F9/445

CPC分类号： G06F17/30174 ,  G06F8/61 ,  G06F9/452

摘要： Disclosed are an application management method and device, applied to a first device connected to a second device. The method includes mapping at least one application in the second device, to obtain at least one corresponding application identifier; detecting a first operation; when the first operation satisfies a first preset condition, determining an application identifier of a first application according to the at least one application identifier; detecting a second operation; when the second operation satisfies a second preset condition, obtaining a corresponding application management command according to the second operation; and sending the application management command to the second device, so that the second device manages the first application according to the application management command.

公开(公告)号：US20150143860A1

公开(公告)日：2015-05-28

申请号：US14553107

申请日：2014-11-25

申请人： Gary David McKnight ,  Randall Linwood Rayborn ,  David Bruce Parker ,  Wei Xu ,  Zehui Yang ,  Raymond Patrick Perkins ,  Andrew Michael Semple

发明人： Gary David McKnight ,  Randall Linwood Rayborn ,  David Bruce Parker ,  Wei Xu ,  Zehui Yang ,  Raymond Patrick Perkins ,  Andrew Michael Semple

IPC分类号： C05G3/08 ,  C05C9/00 ,  C09K15/28 ,  C05D9/02

CPC分类号： C05G3/08 ,  C05C9/00 ,  C05D9/02 ,  C05F3/00 ,  C09K15/28 ,  Y02A40/205 ,  Y02P20/145 ,  Y02P60/218

摘要： Increasing longevity of the nitrogen content of soil through improved liquid delivery formulations of urease inhibitors and/or nitrification inhibitors designed to apply to fertilizers, especially urea and manure based fertilizers These delivery formulations provide an environmentally sound and inherently safe solvating system that improves the storage stability of the urease inhibitors by utilizing aprotic solvents, maintain the urease inhibitors and/or nitrification inhibitors in solution to storage temperatures of at least 10° C. and provides improved application to fertilizer of urease and/or nitrification inhibitors. These delivery formulations enable safe storage, transport and subsequent application or blending with urea based or manure based fertilizers that can be applied to soil in either a liquid or granular form to provide improved nitrogen retention in the soil for uptake for plant life.

摘要翻译： 通过改进的尿素酶抑制剂和/或硝化抑制剂的液体输送配方来改善土壤中氮含量的寿命，其设计用于施用于化肥，特别是尿素和肥料基肥料。这些输送配方提供了一种改善储存稳定性的无害环境和内在安全的溶剂化系统 的脲酶抑制剂通过使用非质子溶剂，将溶液中的脲酶抑制剂和/或硝化抑制剂保持在至少10℃的储存温度，并且提供了对脲酶和/或硝化抑制剂的肥料的改进应用。 这些输送配方使得能够安全地储存，运输和随后的应用或与基于尿素或肥料的肥料混合，其可以以液体或颗粒形式施用于土壤，以在土壤中提供改善的氮保留以吸收植物的寿命。

公开(公告)号：US20150110020A1

公开(公告)日：2015-04-23

申请号：US14385036

申请日：2012-06-07

申请人： Chaofeng Li ,  Ming Lei ,  Wei Xu ,  Le Liang ,  Hua Zhang ,  Shi Jin

发明人： Chaofeng Li ,  Ming Lei ,  Wei Xu ,  Le Liang ,  Hua Zhang ,  Shi Jin

IPC分类号： H04L5/00 ,  H04B15/00 ,  H04W76/02

CPC分类号： H04L5/0053 ,  H04B7/0617 ,  H04B7/0619 ,  H04B7/0626 ,  H04B15/00 ,  H04W76/14

摘要： Methods and apparatuses for interference control have been disclosed. A method for a base station in a wireless communication system, comprising: obtaining a system setting of the wireless communication system; selecting a transmission mode based at least in part on the system setting, wherein the transmission mode is one of an Interference Cancellation IC transmission mode and a Beamforming BF transmission mode; and configuring the selected transmission mode. The total system throughput may be maximized by dynamically switching the transmission mode between IC and BF at the base station. Further, the proposed switching mechanism may be applied to various communication networks where downlink interference may occur.

摘要翻译： 已经公开了用于干扰控制的方法和装置。 一种用于无线通信系统中的基站的方法，包括：获得所述无线通信系统的系统设置; 至少部分地基于系统设置来选择传输模式，其中传输模式是干扰消除IC传输模式和波束形成BF传输模式之一; 以及配置所选择的传输模式。 通过在基站上动态切换IC和BF之间的传输模式，可以使总系统吞吐量最大化。 此外，所提出的切换机制可以应用于可能发生下行链路干扰的各种通信网络。

公开(公告)号：US20140358776A1

公开(公告)日：2014-12-04

申请号：US13908406

申请日：2013-06-03

申请人： Wei Xu ,  Elizabeth Platko

发明人： Wei Xu ,  Elizabeth Platko

IPC分类号： G06Q20/10 ,  G06Q20/36 ,  G06Q20/22

CPC分类号： G06Q20/36 ,  G06Q20/227 ,  G06Q20/3223 ,  G06Q20/405

摘要： A computer processor is used to determine, based on funds data that specifies at least an amount of received funds and a payor associated with a transaction, whether any allocation rule among a plurality of allocation rules is applicable for allocation of the received funds. If an allocation rule is applicable for allocation of the received funds, then the allocation rule is evaluated with the funds data to identify at least one account category, wherein each account category is associated with at least one account of a payee associated with the transaction. At least a portion of the received funds is allocated to at least one of the accounts associated with the identified account category or categories.

摘要翻译： 计算机处理器用于基于指定至少接收到的资金量的资金数据和与交易相关联的付款人来确定多个分配规则中的任何分配规则是否适用于所接收资金的分配。 如果分配规则适用于分配接收到的资金，则用资金数据评估分配规则以识别至少一个账户类别，其中每个账户类别与与交易相关联的收款人的至少一个账户相关联。 所接收的资金的至少一部分被分配给与所识别的帐户类别或类别相关联的至少一个帐户。

公开(公告)号：US08753380B2

公开(公告)日：2014-06-17

申请号：US13376440

申请日：2010-08-02

申请人： Liming Cheng ,  Yan Yu ,  Zhili Zeng ,  Wei Xu ,  Yongwei Jia ,  Lie Qian ,  Rui Zhu ,  Jianjie Wang ,  Zhourui Wu

发明人： Liming Cheng ,  Yan Yu ,  Zhili Zeng ,  Wei Xu ,  Yongwei Jia ,  Lie Qian ,  Rui Zhu ,  Jianjie Wang ,  Zhourui Wu

IPC分类号： A61B17/86

CPC分类号： A61B17/863 ,  A61B17/7032 ,  A61B17/8605 ,  A61B17/862 ,  A61B2017/00004 ,  A61B2090/037

摘要： Techniques are generally described related to a method and system for treating an injury with a bone screw. One example bone screw may be configured to fracture at a pre-selected frangible location so that the point of failure is not in an inaccessible location, e.g., deeply embedded below the surface of a treated bone. The bone screw may further include a material disposed over the frangible location that is designed to temporarily strengthen the screw and selected to be absorbed by the body over a period of time after installation of the screw in the bone. One example bone screw may include an unthreaded portion that is configured to facilitate removal of an embedded screw fragment from a bone in the event that the screw fails in vivo.

摘要翻译： 技术通常涉及用于用骨螺钉治疗损伤的方法和系统。 一个示例性骨螺钉可以被配置为在预先选择的易碎位置处断裂，使得故障点不在不可接近的位置，例如深深地嵌入治疗骨的表面之下。 骨螺钉还可以包括设置在易碎位置上的材料，该材料被设计成临时加强螺钉并且在将螺钉安装在骨中之后的一段时间内被身体吸收。 一个示例性骨螺钉可以包括无螺纹部分，其被配置为在螺钉在体内失效的情况下有助于从骨中去除嵌入的螺钉碎片。

公开(公告)号：US08642559B2

公开(公告)日：2014-02-04

申请号：US12443157

申请日：2007-10-12

申请人： Michel Baudry ,  Wei Xu

发明人： Michel Baudry ,  Wei Xu

IPC分类号： C07K7/00

CPC分类号： A61K38/10 ,  C12Q1/37 ,  G01N33/6896 ,  G01N33/9406 ,  G01N2500/02 ,  G01N2800/28

摘要： A composition comprising a peptide or a peptidomimetic thereof that inhibits the C-terminal domain truncation of mGluR1α by calpain, wherein the peptide is 10-30 amino acids in length and contains a sequence that is at least 70% homologous to VIKPLTKSYQGSGK. Also disclosed are methods of detecting the C-terminal domain truncation of mGluR1α by calpain, methods of inhibiting the C-terminal domain truncation of mGluR1α in a neuron, and methods of identifying a compound that inhibits the C-terminal domain truncation of mGluR1α.

摘要翻译： 一种包含肽或肽模拟物的组合物，其通过钙蛋白酶抑制mGluR1α的C末端结构域截短，其中所述肽的长度为10-30个氨基酸，并且含有与VIKPLTKSYQGSGK至少70％同源的序列。 还公开了通过钙蛋白酶检测mGluR1alpha的C末端结构域截短的方法，抑制神经元中mGluR1alpha的C-末端结构域截短的方法，以及鉴定抑制mGluR1alpha的C末端结构域截短的化合物的方法。

公开(公告)号：US08629080B2

公开(公告)日：2014-01-14

申请号：US13052812

申请日：2011-03-21

申请人： Abdennour Bourane ,  Stephan Ralf Vogel ,  Wei Xu

发明人： Abdennour Bourane ,  Stephan Ralf Vogel ,  Wei Xu

IPC分类号： B01J23/20 ,  C07C29/04

CPC分类号： B01J27/053 ,  B01J23/20 ,  B01J27/195 ,  B01J37/03 ,  B01J37/033 ,  C07C29/04 ,  C07C31/12

摘要： An olefin hydration catalyst and method for producing same is provided. The olefin hydration catalyst can be prepared by contacting a niobium containing compound with a strong Bronsted acid, such as sulfuric or phosphoric acid, to produce niobium oxo sulfate or niobium oxo phosphate nanoparticles. The nanoparticles can be separated, dried and utilized in a reactor for the hydration of olefins to their corresponding alcohols.

摘要翻译： 提供烯烃水合催化剂及其制备方法。 烯烃水合催化剂可以通过使含铌的化合物与强烈的布朗斯台德酸（例如硫酸或磷酸）接触来制备硫酸铌或含氧磷酸铌纳米颗粒。 可以将纳米颗粒分离，干燥并在反应器中用于将烯烃水合成其相应的醇。

公开(公告)号：US20130221279A1

公开(公告)日：2013-08-29

申请号：US13881891

申请日：2011-10-26

申请人： Wei Xu ,  Zehra Serpil Gonen Williams ,  Yijun Wang ,  Robert J. Wiacek ,  Xia Bai ,  Linfeng Gou ,  Selina L. Thomas ,  Jun Xu

发明人： Wei Xu ,  Zehra Serpil Gonen Williams ,  Yijun Wang ,  Robert J. Wiacek ,  Xia Bai ,  Linfeng Gou ,  Selina L. Thomas ,  Jun Xu

IPC分类号： C30B7/14 ,  C30B7/10 ,  C30B29/16 ,  H01B1/00

CPC分类号： C30B29/16 ,  B82Y30/00 ,  B82Y40/00 ,  C01G25/006 ,  C01G25/02 ,  C01G27/006 ,  C01P2006/40 ,  C01P2006/60 ,  C30B7/10 ,  C30B7/14 ,  C30B29/22 ,  C30B33/00 ,  H01B1/00 ,  H01L21/02554 ,  H01L21/02601 ,  H01L21/02628 ,  H01L51/0094 ,  Y10S977/774 ,  Y10S977/896 ,  Y10S977/932

摘要： Preparation of semiconductor nanocrystals and their dispersions in solvents and other media is described. The nanocrystals described herein have small (1-10 nm) particle size with minimal aggregation and can be synthesized with high yield. The capping agents on the as-synthesized nanocrystals as well as nanocrystals which have undergone cap exchange reactions result in the formation of stable suspensions in polar and nonpolar solvents which may then result in the formation of high quality nanocomposite films.

公开(公告)号：US08497284B2

公开(公告)日：2013-07-30

申请号：US13249815

申请日：2011-09-30

申请人： Lynne Canne Bannen ,  Diva Sze-Ming Chan ,  Jeff Chen ,  Lisa Esther Dalrymple ,  Timothy Patrick Forsyth ,  Tai Phat Huynh ,  Vasu Jammalamadaka ,  Richard George Khoury ,  James William Leahy ,  Morrison B. Mac ,  Grace Mann ,  Larry W. Mann ,  John M. Nuss ,  Jason Jevious Parks ,  Craig Stacy Takeuchi ,  Yong Wang ,  Wei Xu

发明人： Lynne Canne Bannen ,  Diva Sze-Ming Chan ,  Jeff Chen ,  Lisa Esther Dalrymple ,  Timothy Patrick Forsyth ,  Tai Phat Huynh ,  Vasu Jammalamadaka ,  Richard George Khoury ,  James William Leahy ,  Morrison B. Mac ,  Grace Mann ,  Larry W. Mann ,  John M. Nuss ,  Jason Jevious Parks ,  Craig Stacy Takeuchi ,  Yong Wang ,  Wei Xu

IPC分类号： A61K31/47

CPC分类号： C07D215/233 ,  A61K31/47 ,  A61K31/4709 ,  A61K31/4725 ,  A61K31/496 ,  A61K31/501 ,  A61K31/505 ,  A61K31/506 ,  A61K31/517 ,  A61K31/5377 ,  C07D215/22 ,  C07D215/36 ,  C07D215/38 ,  C07D215/46 ,  C07D239/88 ,  C07D239/94 ,  C07D295/15 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/14 ,  C07D413/12 ,  C07D413/14 ,  C07D417/12 ,  C12Q1/485 ,  G01N2500/04 ,  Y02A50/393

摘要： The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate, and/or modulate kinase receptor, particularly c-Met, KDF, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.

摘要翻译： 本发明提供调节蛋白激酶酶活性以调节细胞活性如增殖，分化，程序性细胞死亡，迁移和化学侵蚀的化合物。 更具体地，本发明提供抑制，调节和/或调节与细胞活性变化相关的激酶受体，特别是c-Met，KDF，c-Kit，flt-3和flt-4信号转导途径的喹唑啉和喹啉 如上所述，含有这些化合物的组合物，及其用于治疗激酶依赖性疾病和病症的方法。 本发明还提供了制备上述化合物的方法和含有这些化合物的组合物。